<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02328625</url>
  </required_header>
  <id_info>
    <org_study_id>STAR Registry</org_study_id>
    <nct_id>NCT02328625</nct_id>
  </id_info>
  <brief_title>Scleroderma Treatment With Celution Processed ADRCs Registry</brief_title>
  <acronym>STAR</acronym>
  <official_title>Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (ADRCs) Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cytori Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cytori Therapeutics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry study will assess the safety and performance of the Celution Device in the
      processing of an autologous graft consisting of adipose derived regenerative cells (ADRCs) in
      the treatment of hand scleroderma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This registry study will assess the safety and performance of the Celution System in
      preparation of adipose derived regenerative cells in the treatment of scleroderma affecting
      the hands. This will be a multi-center, multi-national study.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Corporate decision
  </why_stopped>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Change in Cochin score</measure>
    <time_frame>Day 90</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Cochin score</measure>
    <time_frame>Days 30 and 180</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scleroderma Health Assessment Questionnaire (SHAQ)</measure>
    <time_frame>Days 7, 30, 90 and 180</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician and Patient Global Assessment</measure>
    <time_frame>Days 7, 30, 90 and 180</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Raynaud's Condition Score</measure>
    <time_frame>Days 7, 30, 90 and 180</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D</measure>
    <time_frame>Days 7, 30, 90 and 180</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Scleroderma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are scheduled to receive or have received ADRCs prepared by Celution to treat
        hand scleroderma.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of scleroderma and presence of hand scleroderma

          -  Cochin score ≥ 20 units

        Exclusion Criteria:

          -  Body Mass Index &lt; 17 kg/m2

          -  Infection in any finger

          -  Stable medications for the treatment of scleroderma for ≥ 1 month

          -  Pregnant or lactating status.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Kesten</last_name>
    <role>Study Chair</role>
    <affiliation>Cytori Therapeutics</affiliation>
  </overall_official>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2014</study_first_submitted>
  <study_first_submitted_qc>December 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2014</study_first_posted>
  <last_update_submitted>March 15, 2016</last_update_submitted>
  <last_update_submitted_qc>March 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Scleroderma</keyword>
  <keyword>Device</keyword>
  <keyword>ADRCs</keyword>
  <keyword>adipose derived regenerative cells</keyword>
  <keyword>hand</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
    <mesh_term>Scleroderma, Localized</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

